Melbourne hosts biotech investment conference

Life sciences investment event AusBiotech Invest Conference will take place from 28-29 October at the Melbourne Convention and Exhibition Centre.

Australia is one of the world’s top biotechnology economies, with 6100 clinical trials registered in 2012 worth more than $1 billion to the Australian economy each year. Victoria hosts 150 companies, 13 major medical research institutes, 10 teaching hospitals and nine universities, collectively employing about 22,000 people in the life sciences sector.

Featuring 40 speakers, 35 companies and more than 300 investors, AusBiotech Invest will cover themes including the sustainability of the local biotech sector, the resurgence of capital flowing into the sector, local success stories, the rising power of Asia and the global state of the biotech industry.

Event highlights include:

• A showcase of 40+ biotech companies looking for investment or partnership opportunities;
• Professional business matching system to set up one-to-one meetings and enhance deal-making;
• Keynotes by leading life science investors and market analysts on the global state of biotechnology;
• Investor and CEO panels discussing strategies for biotech investment, partnering and capital raising;
• Networking opportunities with biotech CEOs, international investors, big pharma representatives, venture capitalists and industry analysts.

With a mix of expert keynotes, investor panels and biotech company presentations, the conference merges market intelligence with investment opportunities and acts as a guide to successful biotech investment.

For more information, visit http://ausbiotechinvest.com/.